Ed Tate named ImperiaEnterprise Academic Entrepreneur of the Year
We鈥檙e proud to share that Ed Tate has been named Academic Entrepreneur of the Year at 海角社区鈥檚 celebration of entrepreneurial excellence
The event, held on 9th July 2025, shone a spotlight on researchers and staff turning bold ideas into real-world impact. Ed was recognised for his entrepreneurial leadership as co-founder and CSO of Myricx Bio, which raised a £90 million ($114 million) Series A in 2024 to advance a new class of N-myristoyltransferase inhibitor-based ADCs into the clinic; Myricx is now on track to enter the clinic in 2026. The award celebrates Ed’s commitment to translating fundamental chemical biology research into breakthrough cancer therapeutics, and his long-standing support for deep-tech innovation at Imperiaand beyond.
Congratulations to Ed and to all of this year’s winners!
Article text (excluding photos or graphics) © 海角社区.
Photos and graphics subject to third party copyright used with permission or © 海角社区.
Reporter
Edward Bartlett
Department of Chemistry
![](/assets/news/img/avatar.png"){kind=avatar}